Computational Design of Protein-Ligand Interfaces - a Therapeutic Strategy
蛋白质-配体界面的计算设计 - 一种治疗策略
基本信息
- 批准号:8854103
- 负责人:
- 金额:$ 29.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAffinityAgingAmino AcidsBacterial InfectionsBindingBinding SitesBiomolecular Nuclear Magnetic ResonanceCationsChemicalsCloningComputer SimulationComputing MethodologiesCovalent InteractionCrystallizationCrystallographyDetectionDevelopmentDiagnosticDockingEducationEnzymesFeedbackGenesGeometryHydrogenHydrogen BondingIndividualInvestmentsLaboratoriesLibrariesLigandsMalignant neoplasm of prostateMapsMethodologyMethodsModelingModificationMolecular ConformationMolecular StructureMutationNuclear Magnetic ResonancePathway interactionsPharmaceutical PreparationsPositioning AttributeProtein BindingProteinsProtocols documentationResearchSamplingSecureSignal TransductionSiteSodium ChlorideSpeedTechniquesTherapeuticUnited States National Institutes of Healthbasebiophysical techniquescocaine overdosedensitydesignexperienceflexibilityfunctional groupimprovedin vivoknowledge basemembermolecular recognitionmutantprogramspublic health relevanceresearch studyscaffoldscreeningsmall moleculesuccesstherapeutic protein
项目摘要
DESCRIPTION (provided by applicant): Proteins that bind small molecules can act as therapeutics by sequestering ligands, stimulating signal- ing pathways, delivering other molecules to sites of action, and serving as in vivo diagnostics. Although the computational design of proteins that can bind to any given ligand is not yet possible, recent successes in de novo enzyme design suggests that it is within reach. Current methods still fail to predict optimal amino acids even in the first shell around the ligand. Short-range interactions with partial covalent character (e.g. hydrogen bonds, salt bridges, and cation-¿-interactions) are often critical for achieving precise positioning within the binding site but are difficult to model becaue their strength is determined by the geometry, polarity, and polarizability of orbitals attached to the interacting functional groups. Existing docking techniques have difficulty handling flexibility
of the binding partners, so the structural plasticity of the interface is not taken into account. W believe that computational de novo design of protein-ligand interfaces can not only expand our under- standing of the basic forces involved in molecular recognition, but can also contribute to the development of protein therapeutics, if certain technological limitations can be overcome. The objective of this proposal is to develop a computational protocol for the de novo design of protein- ligand interfaces. The computational design program, ROSETTA, will be expanded through a new scoring func- tion that uses Knowledge-Based Potentials that capture Partial Covalent Interactions (PCI-KBP) at protein- ligand interfaces. Additionally, a fragment-based approach for sampling small molecule conformations will be implemented. The new sampling strategy models ligand flexibility at the binding interface and exploits the speed of amino acid rotamer sampling used for protein design. The accuracy of the computational models will be assessed through redesign and experimental characterization of a panel of 16 protein mutants, each optimized to bind one small molecule out of a focused library of 16 related compounds. Target binding will be determined for the entire set of 16x16=256 combinations using nuclear magnetic resonance (NMR)-based screening experiments. NMR allows detection of weak binding, determination of binding affinities, and verification of the binding site at atomic-level detail. This approach creates a detailed map of the designed interfaces and captures effects on binding through chemical modification of the ligand (derivatization) as well as the protein (mutation). The matrix of experimentally-determined binding affinities will be compared to those predicted by ROSETTA, providing feedback on the accuracy of individual components of the energy function and the efficiency of the sampling strategy. Page: 1
PUBLIC HEALTH RELEVANCE: This proposal will create advanced methodology to computationally design and experimentally verify protein-ligand interfaces. It will further explore
use of these methods to create protein therapeutics for treatment of prostate cancer, bacterial infection, and cocaine overdosing. Page: 1
描述(由申请人提供):结合小分子的蛋白质可以作为治疗药物,通过隔离配体,刺激信号通路,将其他分子传递到作用位点,并作为体内诊断。虽然计算设计可以与任何给定配体结合的蛋白质尚不可能,但最近在从头设计酶方面的成功表明,这是可以实现的。目前的方法仍然无法预测最佳氨基酸,甚至在配体周围的第一层。具有部分共价特征的短程相互作用(例如氢键、盐桥和阳离子相互作用)通常对实现结合位点内的精确定位至关重要,但很难建模,因为它们的强度取决于相互作用官能团上的轨道的几何形状、极性和极化率。现有的对接技术在处理灵活性方面存在困难
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jens Meiler其他文献
Jens Meiler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jens Meiler', 18)}}的其他基金
Structural Determinants of Allosteric Modulation of Brain GPCRs
脑 GPCR 变构调节的结构决定因素
- 批准号:
10207579 - 财政年份:2019
- 资助金额:
$ 29.63万 - 项目类别:
Structural Determinants of Allosteric Modulation of Brain GPCRs
脑 GPCR 变构调节的结构决定因素
- 批准号:
9979812 - 财政年份:2019
- 资助金额:
$ 29.63万 - 项目类别:
Structural Determinants of Allosteric Modulation of Brain GPCRs
脑 GPCR 变构调节的结构决定因素
- 批准号:
10450746 - 财政年份:2019
- 资助金额:
$ 29.63万 - 项目类别:
Structural Determinants of Allosteric Modulation of Brain GPCRs
脑 GPCR 变构调节的结构决定因素
- 批准号:
10650803 - 财政年份:2019
- 资助金额:
$ 29.63万 - 项目类别:
Structural Determinants of Human Antibodies neutralizing the Ebola Virus
中和埃博拉病毒的人类抗体的结构决定因素
- 批准号:
9304960 - 财政年份:2016
- 资助金额:
$ 29.63万 - 项目类别:
Small Molecule Probes to Investigate Structure and Function of Y Receptors
研究 Y 受体结构和功能的小分子探针
- 批准号:
8578312 - 财政年份:2013
- 资助金额:
$ 29.63万 - 项目类别:
Small Molecule Probes to Investigate Structure and Function of Y Receptors
研究 Y 受体结构和功能的小分子探针
- 批准号:
8890156 - 财政年份:2013
- 资助金额:
$ 29.63万 - 项目类别:
Computational Design of Protein-Ligand Interfaces - a Therapeutic Strategy
蛋白质-配体界面的计算设计 - 一种治疗策略
- 批准号:
8372321 - 财政年份:2012
- 资助金额:
$ 29.63万 - 项目类别:
Computational Design of Protein-Ligand Interaces - a Therapeutic Strategy
蛋白质-配体相互作用的计算设计 - 一种治疗策略
- 批准号:
8551916 - 财政年份:2012
- 资助金额:
$ 29.63万 - 项目类别:
Computational Design of Protein-Ligand Interfaces - a Therapeutic Strategy
蛋白质-配体界面的计算设计 - 一种治疗策略
- 批准号:
8664893 - 财政年份:2012
- 资助金额:
$ 29.63万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 29.63万 - 项目类别:
Continuing Grant